Chemed (CHE) is down -14.0%, or -$78.52 to $480.84.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE:
- Chemed falls -10.1%
- Chemed price target lowered to $640 from $674 at RBC Capital
- Oppenheimer says Chemed should be down significantly on Vitas Florida Cap impact
- Chemed price target lowered to $650 from $708 at BofA
- Chemed’s Resilience Amid Challenges: Justifying a Buy Rating with Strong Long-Term Prospects